Estrogen receptor beta as a mitochondrial vulnerability factor.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMC 2666606)

Published in J Biol Chem on February 03, 2009

Authors

Shao-Hua Yang1, Saumyendra N Sarkar, Ran Liu, Evelyn J Perez, Xiaofei Wang, Yi Wen, Liang-Jun Yan, James W Simpkins

Author Affiliations

1: Department of Pharmacology and Neuroscience, Institute for Aging and Alzheimer's Disease Research, University of North Texas Health Science Center, Fort Worth, Texas 76107, USA. syang@hsc.unt.edu

Articles citing this

Estrogen signaling and cardiovascular disease. Circ Res (2011) 1.59

Estrogen receptor signaling in lung cancer. Semin Oncol (2009) 1.36

Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. Biochim Biophys Acta (2009) 1.26

Mitochondrial mechanisms of estrogen neuroprotection. Biochim Biophys Acta (2009) 1.25

Role of estrogen receptor alpha and beta expression and signaling on cognitive function during aging. Hippocampus (2011) 1.13

Estrogen-receptor-mediated protection of cerebral endothelial cell viability and mitochondrial function after ischemic insult in vitro. J Cereb Blood Flow Metab (2009) 1.01

Estrogen represses hepatocellular carcinoma (HCC) growth via inhibiting alternative activation of tumor-associated macrophages (TAMs). J Biol Chem (2012) 1.00

Ligand-independent antiapoptotic function of estrogen receptor-beta in lung cancer cells. Mol Endocrinol (2010) 0.97

Protective Action of Neurotrophic Factors and Estrogen against Oxidative Stress-Mediated Neurodegeneration. J Toxicol (2011) 0.96

Role of estrogen receptor α and β in preserving hippocampal function during aging. J Neurosci (2013) 0.95

Sexually-dimorphic targeting of functionally-related genes in COPD. BMC Syst Biol (2014) 0.94

Neuroglobin upregulation induced by 17β-estradiol sequesters cytocrome c in the mitochondria preventing H2O2-induced apoptosis of neuroblastoma cells. Cell Death Dis (2013) 0.91

Glucocorticoid and estrogen receptors are reduced in mitochondria of lung epithelial cells in asthma. PLoS One (2012) 0.85

Glucose metabolism and hexosamine pathway regulate oncogene-induced senescence. Cell Death Dis (2014) 0.84

Estrogen receptor-α but not -β or GPER inhibits high glucose-induced human VSMC proliferation: potential role of ROS and ERK. J Clin Endocrinol Metab (2010) 0.84

Estrogen amelioration of Aβ-induced defects in mitochondria is mediated by mitochondrial signaling pathway involving ERβ, AKAP and Drp1. Brain Res (2015) 0.81

Ligand-dependent differences in estrogen receptor beta-interacting proteins identified in lung adenocarcinoma cells corresponds to estrogenic responses. Proteome Sci (2011) 0.80

Estrogen receptor alpha activation enhances mitochondrial function and systemic metabolism in high-fat-fed ovariectomized mice. Physiol Rep (2016) 0.77

Estrogen-induced signaling attenuates soluble Aβ peptide-mediated dysfunction of pathways in synaptic plasticity. Brain Res (2011) 0.77

Protective actions of 17β-estradiol and progesterone on oxidative neuronal injury induced by organometallic compounds. Oxid Med Cell Longev (2015) 0.76

A novel mutation m.8561C>G in MT-ATP6/8 causing a mitochondrial syndrome with ataxia, peripheral neuropathy, diabetes mellitus, and hypergonadotropic hypogonadism. J Neurol (2016) 0.76

Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells. J Natl Cancer Inst (2017) 0.76

A High-Cholesterol Diet Increases 27-Hydroxycholesterol and Modifies Estrogen Receptor Expression and Neurodegeneration in Rabbit Hippocampus. J Alzheimers Dis (2016) 0.75

Articles cited by this

Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A (1996) 10.94

Mitochondrial control of cell death. Nat Med (2000) 9.17

Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci U S A (1993) 7.13

Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A (1998) 5.86

Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods (2002) 5.30

ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett (1996) 4.77

Sequence and expression of human estrogen receptor complementary DNA. Science (1986) 4.36

Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol (2005) 3.44

Estrogen receptors alpha and beta form heterodimers on DNA. J Biol Chem (1997) 2.39

Ultrastructural evidence that hippocampal alpha estrogen receptors are located at extranuclear sites. J Comp Neurol (2001) 2.31

ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology (2001) 2.18

Mitochondrial localization of estrogen receptor beta. Proc Natl Acad Sci U S A (2004) 2.15

Roles of estrogen receptor-alpha gene expression in reproduction-related behaviors in female mice. Endocrinology (1998) 2.05

Oestrogen as a neuroprotective hormone. Nat Rev Neurosci (2002) 2.03

Ultrastructural localization of estrogen receptor beta immunoreactivity in the rat hippocampal formation. J Comp Neurol (2005) 1.97

Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol Endocrinol (1997) 1.90

Sex steroids and bone. Physiol Rev (2001) 1.88

Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer (2004) 1.84

Structure-function relationship of estrogen receptor alpha and beta: impact on human health. Mol Aspects Med (2006) 1.80

Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling. Proc Natl Acad Sci U S A (2003) 1.77

Reflections on the discovery and significance of estrogen receptor beta. Endocr Rev (2005) 1.75

Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer. Breast Cancer Res (2000) 1.69

Mitochondrial localization of ERalpha and ERbeta in human MCF7 cells. Am J Physiol Endocrinol Metab (2004) 1.66

Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene (2005) 1.65

Estrogen receptor beta--a new dimension in estrogen mechanism of action. J Endocrinol (1999) 1.64

Role of estrogen receptor beta in colonic epithelium. Proc Natl Acad Sci U S A (2006) 1.49

Estrogen receptors alpha and beta mediate distinct pathways of vascular gene expression, including genes involved in mitochondrial electron transport and generation of reactive oxygen species. Mol Endocrinol (2007) 1.47

Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis. FEBS Lett (2004) 1.45

Mitochondria as therapeutic targets of estrogen action in the central nervous system. Curr Drug Targets CNS Neurol Disord (2004) 1.38

A comparison of transcriptional activation by ER alpha and ER beta. J Steroid Biochem Mol Biol (1999) 1.31

Estrogen receptor alpha and beta immunoreactive neurons in normal adult and aged female rat hippocampus: a qualitative and quantitative study. Brain Res (2005) 1.26

Tracking the estrogen receptor in neurons: implications for estrogen-induced synapse formation. Proc Natl Acad Sci U S A (2001) 1.21

Estrogen receptor transcription and transactivation: Estrogen receptor knockout mice: what their phenotypes reveal about mechanisms of estrogen action. Breast Cancer Res (2000) 1.21

Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells. J Neurochem (2001) 1.16

Oxidative damage to human lens epithelial cells in culture: estrogen protection of mitochondrial potential, ATP, and cell viability. Invest Ophthalmol Vis Sci (2003) 1.15

Neuroendocrine modulation and repercussions of female reproductive aging. Recent Prog Horm Res (2002) 1.14

Gender and risk of autoimmune diseases: possible role of estrogenic compounds. Environ Health Perspect (1999) 1.10

Mitochondria play a central role in estrogen-induced neuroprotection. Curr Drug Targets CNS Neurol Disord (2005) 1.08

Estrogen receptors alpha and beta (ERalpha and ERbeta) and androgen receptor (AR) in human sperm: localization of ERbeta and AR in mitochondria of the midpiece. Hum Reprod (2005) 1.08

Extranuclear estrogen receptor beta immunoreactivity is on doublecortin-containing cells in the adult and neonatal rat dentate gyrus. Brain Res (2006) 1.07

Cardiovascular effects of oestrogens. J Steroid Biochem Mol Biol (2000) 1.05

Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis. Cancer Lett (2006) 1.03

Differences in the abilities of estrogen receptors to integrate activation functions are critical for subtype-specific transcriptional responses. Mol Endocrinol (2002) 1.00

Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications. Biochim Biophys Acta (2005) 0.99

Signalling through nuclear receptors. Nat Rev Mol Cell Biol (2002) 0.99

Estrogen replacement and cardiomyocyte protection. Trends Cardiovasc Med (2006) 0.98

Subcellular distribution of native estrogen receptor alpha and beta subtypes in cultured human lens epithelial cells. Exp Eye Res (2004) 0.97

Estrogen receptor beta (ERbeta) is expressed in brain astrocytic tumors and declines with dedifferentiation of the neoplasm. J Cancer Res Clin Oncol (2004) 0.95

Estrogen receptor beta in prostate cancer: brake pedal or accelerator? Am J Pathol (2001) 0.94

Estrogen therapy: does it help or hurt the adult and aging brain? Insights derived from animal models. Neuroscience (2005) 0.93

Measurements of vector-derived neurotrophic factor and green fluorescent protein levels in the brain. Methods (2002) 0.92

Can estrogen keep you smart? Evidence from clinical studies. J Psychiatry Neurosci (1999) 0.91

Estrogens as protectants of the neurovascular unit against ischemic stroke. Curr Drug Targets CNS Neurol Disord (2005) 0.91

Estrogen, mitochondria, and growth of cancer and non-cancer cells. J Carcinog (2005) 0.90

Differential subcellular distribution of estrogen receptor isoforms: localization of ERalpha in the nucleoli and ERbeta in the mitochondria of human osteosarcoma SaOS-2 and hepatocarcinoma HepG2 cell lines. Biochim Biophys Acta (2005) 0.90

Differential expression and comparative subcellular localization of estrogen receptor beta isoforms in virally transformed and normal cultured human lens epithelial cells. Exp Eye Res (2005) 0.87

Estrogen receptor beta is expressed in human embryonic brain cells and is regulated by 17beta-estradiol. Eur J Neurosci (2004) 0.86

Regulatory roles of presenilin-1 and nicastrin in neuronal differentiation during in vitro neurogenesis. J Neurochem (2003) 0.85

Rapid uptake and binding of estradiol-17beta-6-(O-carboxymethyl)oxime:125I-labeled BSA by female rat liver. Biol Reprod (1998) 0.85

Novel estrogen receptor beta transcript variants identified in human breast cancer cells affect cell growth and apoptosis of COS-1 cells. Mol Cell Endocrinol (2006) 0.77

Articles by these authors

A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement (2009) 10.21

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol (2010) 5.99

Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. Neuron (2007) 3.98

Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice. Nat Genet (2003) 3.78

Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice. Cell (2007) 3.54

Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203. J Clin Oncol (2008) 3.02

Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci U S A (2005) 2.95

Choroidal thickness in both eyes of patients with unilateral idiopathic macular hole. Ophthalmology (2012) 2.78

Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial. J Clin Oncol (2012) 2.76

Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia. J Neurosci (2007) 2.68

Current progress of China's free ART program. Cell Res (2005) 2.59

Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105. J Clin Oncol (2008) 2.40

Mitochondrial localization of estrogen receptor beta. Proc Natl Acad Sci U S A (2004) 2.15

Choroidal thickness in healthy Chinese subjects. Invest Ophthalmol Vis Sci (2011) 1.74

Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males. Aging Cell (2013) 1.71

Complement 3 activates the renal renin-angiotensin system by induction of epithelial-to-mesenchymal transition of the nephrotubulus in mice. Am J Physiol Renal Physiol (2013) 1.59

Increased beta-secretase activity and expression in rats following transient cerebral ischemia. Brain Res (2004) 1.59

Heat shock factor 1 and heat shock proteins: critical partners in protection against acute cell injury. Crit Care Med (2002) 1.58

How do statistical properties influence findings of tracking (maintenance) in epidemiologic studies? An example of research in tracking of obesity. Eur J Epidemiol (2003) 1.58

Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Repair Regen (2002) 1.51

Mycoplasma genitalium infections in asymptomatic men and men with urethritis attending a sexually transmitted diseases clinic in New Orleans. Clin Infect Dis (2002) 1.49

The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584. Cancer Res (2004) 1.47

Randomized phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small-cell lung cancer: Cancer and Leukemia Group B trial 30407. J Clin Oncol (2011) 1.45

Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104. J Clin Oncol (2010) 1.44

Gene expression in vivo shows that Helicobacter pylori colonizes an acidic niche on the gastric surface. Proc Natl Acad Sci U S A (2007) 1.42

Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103. J Clin Oncol (2008) 1.41

Alternative mitochondrial electron transfer as a novel strategy for neuroprotection. J Biol Chem (2011) 1.41

Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection. Proc Natl Acad Sci U S A (2003) 1.37

A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein. PLoS One (2011) 1.36

Repulsive Wnt signaling inhibits axon regeneration after CNS injury. J Neurosci (2008) 1.36

Testosterone increases neurotoxicity of glutamate in vitro and ischemia-reperfusion injury in an animal model. J Appl Physiol (1985) (2002) 1.35

Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: cancer and leukemia group B (CALEB) 30106, a CALGB-stratified phase II trial. J Thorac Oncol (2010) 1.34

Spatial and temporal expression of MFRP and its interaction with CTRP5. Invest Ophthalmol Vis Sci (2006) 1.30

CTRP5 is a membrane-associated and secretory protein in the RPE and ciliary body and the S163R mutation of CTRP5 impairs its secretion. Invest Ophthalmol Vis Sci (2006) 1.29

De novo sequencing and analysis of root transcriptome using 454 pyrosequencing to discover putative genes associated with drought tolerance in Ammopiptanthus mongolicus. BMC Genomics (2012) 1.29

Estrogen attenuates nuclear factor-kappa B activation induced by transient cerebral ischemia. Brain Res (2004) 1.29

Pyruvate protects mitochondria from oxidative stress in human neuroblastoma SK-N-SH cells. Brain Res (2006) 1.28

Estrogens and progesterone as neuroprotectants: what animal models teach us. Front Biosci (2008) 1.25

Transcriptional inhibition of progressive renal disease by gene silencing pyrrole-imidazole polyamide targeting of the transforming growth factor-β1 promoter. Kidney Int (2010) 1.23

Adventitious root formation in rice requires OsGNOM1 and is mediated by the OsPINs family. Cell Res (2009) 1.22

Estrogens directly potentiate neuronal L-type Ca2+ channels. Proc Natl Acad Sci U S A (2008) 1.22

Acid acclimation by Helicobacter pylori. Physiology (Bethesda) (2005) 1.21

Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats. Biochim Biophys Acta (2006) 1.20

17beta-Estradiol attenuates blood-brain barrier disruption induced by cerebral ischemia-reperfusion injury in female rats. Brain Res (2005) 1.18

Genes of Helicobacter pylori regulated by attachment to AGS cells. Infect Immun (2004) 1.17

Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma. Oncol Rep (2012) 1.16

A method for generating uniform size-segregated pyrite particle fractions. Geochem Trans (2007) 1.16

Neuroprotective effects of an estratriene analog are estrogen receptor independent in vitro and in vivo. Brain Res (2005) 1.16

Oxidative damage to human lens epithelial cells in culture: estrogen protection of mitochondrial potential, ATP, and cell viability. Invest Ophthalmol Vis Sci (2003) 1.15

Controlled electrochemical synthesis of conductive polymer nanotube structures. J Am Chem Soc (2007) 1.14

Methylene blue as a cerebral metabolic and hemodynamic enhancer. PLoS One (2012) 1.12

Nano-embossing technology on ferroelectric thin film Pb(Zr0.3,Ti0.7)O3 for multi-bit storage application. Nanoscale Res Lett (2011) 1.12

Estrogen actions on mitochondria--physiological and pathological implications. Mol Cell Endocrinol (2008) 1.11

Antiretroviral therapy adherence among patients living with HIV/AIDS in Thailand. Nurs Health Sci (2010) 1.11

GDNF modifies reactive astrogliosis allowing robust axonal regeneration through Schwann cell-seeded guidance channels after spinal cord injury. Exp Neurol (2011) 1.11

Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904. J Clin Oncol (2009) 1.10

Chlamydia psittaci genetic variants differ in virulence by modulation of host immunity. J Infect Dis (2011) 1.10

Estrogen-like compounds for ischemic neuroprotection. Stroke (2004) 1.10

Different impacts of blood pressure variability on the progression of cerebral microbleeds and white matter lesions. Stroke (2012) 1.10

Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies. Cancer Res (2009) 1.09

Novel mechanisms for estrogen-induced neuroprotection. Exp Biol Med (Maywood) (2006) 1.09

Hypoxia-inducible factor 2alpha regulates expression of the mitochondrial aconitase chaperone protein frataxin. J Biol Chem (2007) 1.09

Structure-nongenomic neuroprotection relationship of estrogens and estrogen-derived compounds. Pharmacol Ther (2007) 1.09

A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment. Neurobiol Dis (2008) 1.09

Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells. Invest Ophthalmol Vis Sci (2003) 1.09

Mitochondria play a central role in estrogen-induced neuroprotection. Curr Drug Targets CNS Neurol Disord (2005) 1.08

Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein. Brain Res (2004) 1.08

Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like tauopathy in female rats. J Biol Chem (2004) 1.07

Individual attitudes and perceived social norms: Reports on HIV/AIDS-related stigma among service providers in China. Int J Psychol (2009) 1.07

Immunohistochemical localization of EGF, TGF-alpha, TGF-beta, and their receptors in rat corneas during healing of excimer laser ablation. Curr Eye Res (2006) 1.07

Protein Oxidative Modifications: Beneficial Roles in Disease and Health. J Biochem Pharmacol Res (2013) 1.07

Neuroprotective effects of 17beta-estradiol and nonfeminizing estrogens against H2O2 toxicity in human neuroblastoma SK-N-SH cells. Mol Pharmacol (2006) 1.06

Gastric infection by Helicobacter pylori. Curr Gastroenterol Rep (2011) 1.06

A novel probe for the non-invasive detection of tumor-associated inflammation. Oncoimmunology (2013) 1.05

Roles of AMP-activated protein kinase in Alzheimer's disease. Neuromolecular Med (2012) 1.05

Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles. Int J Nanomedicine (2011) 1.05

Estrogen protects the inner retina from apoptosis and ischemia-induced loss of Vesl-1L/Homer 1c immunoreactive synaptic connections. Invest Ophthalmol Vis Sci (2003) 1.05

Antitumor activity of the histone deacetylase inhibitor MS-275 in prostate cancer models. Prostate (2007) 1.05

Activation of the p38 MAP kinase pathway is required for foam cell formation from macrophages exposed to oxidized LDL. APMIS (2002) 1.03